237 related articles for article (PubMed ID: 28450058)
1. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.
Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE
Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HBV replication by N-hydroxyisoquinolinedione and N-hydroxypyridinedione ribonuclease H inhibitors.
Edwards TC; Mani N; Dorsey B; Kakarla R; Rijnbrand R; Sofia MJ; Tavis JE
Antiviral Res; 2019 Apr; 164():70-80. PubMed ID: 30768944
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.
Cai CW; Lomonosova E; Moran EA; Cheng X; Patel KB; Bailly F; Cotelle P; Meyers MJ; Tavis JE
Antiviral Res; 2014 Aug; 108():48-55. PubMed ID: 24858512
[TBL] [Abstract][Full Text] [Related]
4. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
Hu Y; Cheng X; Cao F; Huang A; Tavis JE
Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and cytotoxicity in cell culture of novel α-hydroxytropolone inhibitors of hepatitis B virus ribonuclease H.
Lomonosova E; Daw J; Garimallaprabhakaran AK; Agyemang NB; Ashani Y; Murelli RP; Tavis JE
Antiviral Res; 2017 Aug; 144():164-172. PubMed ID: 28633989
[TBL] [Abstract][Full Text] [Related]
6. A mid-throughput HBV replication inhibition assay capable of detecting ribonuclease H inhibitors.
Li Q; Edwards TC; Ponzar NL; Tavis JE
J Virol Methods; 2021 Jun; 292():114127. PubMed ID: 33766659
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.
Tavis JE; Cheng X; Hu Y; Totten M; Cao F; Michailidis E; Aurora R; Meyers MJ; Jacobsen EJ; Parniak MA; Sarafianos SG
PLoS Pathog; 2013 Jan; 9(1):e1003125. PubMed ID: 23349632
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.
Lu G; Villa JA; Donlin MJ; Edwards TC; Cheng X; Heier RF; Meyers MJ; Tavis JE
Antiviral Res; 2016 Nov; 135():24-30. PubMed ID: 27693161
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV RNaseH Inhibitors.
Lomonosova E; Tavis JE
Methods Mol Biol; 2017; 1540():179-192. PubMed ID: 27975316
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus ribonuclease H as a drug target.
Tavis JE; Lomonosova E
Antiviral Res; 2015 Jun; 118():132-8. PubMed ID: 25862291
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity.
Yamashita A; Tamaki M; Kasai H; Tanaka T; Otoguro T; Ryo A; Maekawa S; Enomoto N; de Voogd NJ; Tanaka J; Moriishi K
Antiviral Res; 2017 Sep; 145():136-145. PubMed ID: 28827084
[TBL] [Abstract][Full Text] [Related]
12. Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity.
Lu G; Lomonosova E; Cheng X; Moran EA; Meyers MJ; Le Grice SF; Thomas CJ; Jiang JK; Meck C; Hirsch DR; D'Erasmo MP; Suyabatmaz DM; Murelli RP; Tavis JE
Antimicrob Agents Chemother; 2015 Feb; 59(2):1070-9. PubMed ID: 25451058
[TBL] [Abstract][Full Text] [Related]
13. Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication.
Li Q; Lomonosova E; Donlin MJ; Cao F; O'Dea A; Milleson B; Berkowitz AJ; Baucom JC; Stasiak JP; Schiavone DV; Abdelmessih RG; Lyubimova A; Fraboni AJ; Bejcek LP; Villa JA; Gallicchio E; Murelli RP; Tavis JE
Antiviral Res; 2020 May; 177():104777. PubMed ID: 32217151
[TBL] [Abstract][Full Text] [Related]
14. Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.
Villa JA; Pike DP; Patel KB; Lomonosova E; Lu G; Abdulqader R; Tavis JE
Antiviral Res; 2016 Aug; 132():186-95. PubMed ID: 27321664
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice.
Long KR; Lomonosova E; Li Q; Ponzar NL; Villa JA; Touchette E; Rapp S; Liley RM; Murelli RP; Grigoryan A; Buller RM; Wilson L; Bial J; Sagartz JE; Tavis JE
Antiviral Res; 2018 Jan; 149():41-47. PubMed ID: 29129708
[TBL] [Abstract][Full Text] [Related]
17. Chemical Approaches to Inhibiting the Hepatitis B Virus Ribonuclease H.
Tavis JE; Zoidis G; Meyers MJ; Murelli RP
ACS Infect Dis; 2019 May; 5(5):655-658. PubMed ID: 29565562
[TBL] [Abstract][Full Text] [Related]
18. Identification and assessment of the 1,6-dihydroxy-pyridin-2-one moiety as privileged scaffold for HBV ribonuclease H inhibition.
Giannakopoulou E; Pardali V; Edwards TC; Woodson M; Tajwar R; Tavis JE; Zoidis G
Antiviral Res; 2024 Mar; 223():105833. PubMed ID: 38325606
[TBL] [Abstract][Full Text] [Related]
19. Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.
Tramontano E; Corona A; Menéndez-Arias L
Antiviral Res; 2019 Nov; 171():104613. PubMed ID: 31550450
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
